High Tide Reports Record Q3 Earnings, Eyes Expansion

High Tide (NASDAQ: HITI) just posted another standout quarter for Q3 2025, and the numbers tell the story.  CEO Raj Grover joins the Trade to Black podcast to discuss the results, noting that Q3 is traditionally High Tide’s strongest quarter, but this year delivered record revenue, adjusted EBITDA, and net income.

Here’s the highlights: Same-store sales were up 7.4% year-over-year — the fastest growth rate in two years. Free Cash Flow came in at $7.7 million in Q3 2025, up 148% YoY and 57% sequentially. The company also reported positive Net Income of $832,000, a 1% increase YoY and a meaningful turnaround from a net loss of $2.8 million last quarter. Market share continues to expand, with Canna Cabana holding 12% of cannabis retail sales in its five core provinces during May and June 2025, up from 11% the previous year. High Tide also remains the highest revenue-generating Canadian cannabis company reporting in CAD, with a Q3 annualized revenue run rate of $600 million.

Grover attributes the performance to the company’s discount club retail model, disciplined site selection, and strong customer loyalty. Membership in the Canna Cabana Club rose to 2.15 million, including 115,000 elite members, a segment that grew 102% year over year. Grover says membership growth remains the company’s “supreme focus,” with a long-term goal of surpassing 3 million members.

We’ll cover what these Q3 2025 results mean for High Tide’s competitive position — from membership growth and market share expansion to new opportunities in hemp-derived cannabinoids in the U.S. and the German market through Remexian, where the company has a 16% share of grams sold. We’ll also break down recent share price action, which saw High Tide surge above $3.62 to $4.68 before settling around $3.70.

How should investors interpret High Tide’s performance heading into 2026? We’ll share our thoughts in this interview with Raj Grover.


You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More